SUBSCRIBE
SUBSCRIBE
News   FDA

ZymoGenetics, Inc. Drug Gets Canadian Approval

December 16, 2009 | 
1 min read
Bookmark and Share

ZymoGenetics, the Seattle-based biotech company, said today in a regulatory filing that its drug to control excess surgical bleeding has received approval from Canadian regulators.
FDA Approvals
MORE ON THIS TOPIC
Minimal Clip Art Collage. Pop Vector Design Composition with bright bold geometric shapes, halftone objects for ad, animation etc
Approvals
J&J Steps Into Crowded Myasthenia Gravis Market With FDA Nod
May 1, 2025
 · 
2 min read
 · 
Tristan Manalac
complex business management or organization, distraction and complicated business process
Government
FDA Misses Another Deadline Amid Staff Exodus, Structural Disruptions
May 1, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
Tariffs Continue to Dominate Q1 Earnings, AACR Excites Cancer Space, CEO Pay Gaps, More
April 30, 2025
 · 
1 min read
 · 
Heather McKenzie
Artificial skin technology linear icon. Editable stroke. Minimalist medical concept. Medical innovation for tissue regeneration and wound healing. Vector illustration isolated on a white background.
Rare diseases
Abeona Gets FDA Nod for Rare Skin Disease Gene Therapy
April 29, 2025
 · 
1 min read
 · 
Dan Samorodnitsky